LEAFLET THICKENING OR IMMOBILITY IN TRANSCATHETER OR SURGICAL AORTIC VALVES: RESULTS FROM THE EVOLUT LOW RISK LTI SUBSTUDY
Sign Up to like & getrecommendations! Published in 2020 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(20)31728-9
Abstract: A substudy of the Evolut Low Risk Trial assessed the incidence and clinical impact of valve leaflet thickening and restricted mobility after transcatheter aortic valve replacement (TAVR) and surgical AVR (SAVR). ECG-gated multi-detector computed tomography… read more here.
Keywords: low risk; evolut low; substudy; leaflet thickening ... See more keywords
Clinical Impact of Hypoattenuating Leaflet Thickening After Transcatheter Aortic Valve Replacement
Sign Up to like & getrecommendations! Published in 2022 at "Circulation: Cardiovascular Interventions"
DOI: 10.1161/circinterventions.121.011480
Abstract: Background: Hypoattenuated leaflet thickening (HALT), identified on functional cardiac computed tomography (CTA), can affect valve function and clinical outcomes. The objective of this study was to assess the impact of HALT on clinical outcomes in… read more here.
Keywords: transcatheter aortic; leaflet thickening; valve; halt patients ... See more keywords